Abstract
In order to advise rational treatment it is necessary to define and to classify the conditions known as cardiomyopathies. Cardiomyopathies are defined as “Heart Muscle Diseases of Unknown Causes” to distinguish them from myocardial diseases due to disorders of other systems; the “Specific Heart Muscle Diseases”. This lecture is concerned with the treatment of cardiomyopathies so defined.
Keywords
- Mitral Regurgitation
- Infective Endocarditis
- Hypertrophic Cardiomyopathy
- Ventricular Volume
- Mitral Valve Replacement
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Alvares, R., 1980, Diastolic function and prognosis in hypertrophic cardiomyopathy, PhD Thesis, University of London.
Braimbridge, M. V., Darracott, S., Chayen, J., Bitensby, L., Poulter, L. W., 1967, Possibility of a new infective etiological agent in congestive cardiomyopathy, Lancet, 1:171–176.
Cambridge, G., MacArthur, C. G. C., Waterson, A. P., Goodwin, J. F., Oakley, C. M., 1979, Antibodies to Coxsackie B virus in congestive cardiomyopathy, Brit. Heart J., 41:692.
Criley, J. M. et al., 1965, Pressure gradients without obstruction: a new concept of hypertrophic subaortic stenosis, Circulation, 32:881.
Davies, J., Sapsford, R., Tai, P. C., Spry, C. J. F., Goodwin, J. F., 1981, Löffler’s endomyocardial disease — cardiological and immunological study of nine patients with report of successful surgery in three patients, Brit. Heart J., 45:338 (P).
Dubost, C., Marine, P., Gerbaux, A., Bertrand, E., Rulliere, R., Vial, F., Barrillon, A., Prigent, C., Carpenter, A., Soyer, R., 1976, Surgical treatment of constrictive fibrous endocarditis, Ann. Surg., 184:303–307.
Fitchett, D. H., Marin Neto J. A., Oakley, C. M., Goodwin, J. F., 1979, Hydrallazine in the assessment of left ventricular failure, Amer. J. Cardiol., 44:30.
Fowler, B. B., Bieber, C. P., Stinson, E. B., 1979, Defective in vitro suppressor cell dysfunction in idiopathic congestive cardiomyopathy, Circulation, 59:483.
Frank, M. J. et al., 1978, Long term medical management of hypertrophic obstructive cardiomyopathy, Amer. J. Cardiol., 42:993.
Fuster, V. et al., 1982, Idiopathic dilated congestive cardiomyopathy — observations on the natural history, in: “Congestive Cardiomyopathy”, eds., Goodwin, J. F., Hjalmarsson, A. and Olsen, E. G. J., Hessle, Molndal, Sweden, p. 208.
Goodwin, J. F., Oakley, C. M., 1972, The Cardiomyopathies, Brit. Heart J., 34:595.
Goodwin, J. F., 1974, International Lecture: Prospects and predictions for the cardiomyopathies, Circulation, 50:210.
Goodwin, J. F., Krikler, D. M., 1976, Arrhythmia as a cause of sudden death in hypertrophic cardiomyopathy, Lancet, 2:937–940.
Goodwin, J. F., 1979, Cardiomyopathy: an interface between fundamental and clinical cardiology, in: “Cardiology”, ed., Hayase and Murao, Excerpta Medica Amsterdam, p. 103.
Goodwin, J. F., 1981, The frontiers of cardiomyopathy, Brit. Heart J., to be published.
Goodwin, J. F., 1982, The frontiers of cardiomyopathy, Brit. Heart J., in press.
Hubner, P. J. B., Ziady, G. M., Raine, G. K., Hardarson, T., Scales, B., Oakley, C. M., Goodwin, J. F., 1973, Double blind trial of Propranolol, and Practolol in hypertrophic cardiomyopathy, Brit. Heart J., 35:1116.
Kaltenbach, M., Hopf, R., Kober, G., Bussman, W.-D., Keller, M., Peterson, Y., 1979, Treatment of hypertrophic obstructive cardiomyopathy with Verapamil, Brit. Heart J., 42:35–42.
Kawii, C., 1971, Idiopathic cardiomyopathy. A study on the infection/ immune theory as a cause of the disease, Jap. Circ. J., 35:765.
Kuhn, H., Krelhaw, W., Bircks, W., Schulte, H. D., Loogen, F., 1978, Indication for surgical treatment in patients with hypertrophic obstructive cardiomyopathy, in: “Cardiomyopathy and myocardial biopsy”,Eds., Kaltenbach, Loogen, Olsen, Springer Verlag, Berlin, p. 308.
Lorell, B. H., Poulus, Grossman, W., Fulton, M. A., Wynne, J., Cohn, P. F., 1980, Improved diastolic compliance in hypertrophic cardiomyopathy treated with Nifedipine, Circulation, 3:62, 317.
MacArthur, C. G. C. et al., 1982, The effect of left ventricular function, arrhythmias and evidence of previous viral infection on the prognosis of congestive cardiomyopathy, in: “Congestive Cardiomyopathy”, eds., Goodwin, J. F., Hjalmarsson, A. and Olsen, E. G. J., Hessle, Molndal, Sweden, p. 236.
McKenna, W. J., Chetty, S., Oakley, C. M., Goodwin, J. F., 1980, Arrhythmias in hypertrophic cardiomyopathy; exercise electrocardiogram and 48 hour ambulatory electrocardiographic assessment with and without beta adrenergic blocking therapy, Amer. J. Cardiol., 45:1–5.
McKenna, W. J., England, D., Doi, Y. C., Deanfield, J. E., Oakley, C. M., Goodwin, J. F., 1981<sup>a</sup>, Arrhythmias in hypertrophic cardiomyopathy: I, influence on prognosis, Brit. Heart J., in press.
McKenna, W., Deanfield, J., Faruqui, A., England, D., Oakley, C., Goodwin, J. F., 1981b, Prognosis in hypertrophic cardiomyopathy. Role of age and clinical electrocardiographic and hemodynamic features, Amer. J. Cardiol., 47:532.
McKenna, W. J., Harris, L., Perez, G., Krikler, D. M., Oakley, C. M., Goodwin, J. F., 1981<sup>c</sup>, Arrhythmias in hypertrophic cardiomyopathy: II, comparison of Amiodarone and Verapamil in treatment, Brit. Heart J., in press.
Maron, B. J., Merrill, W. H., Freier, P. A., Kent, K. M., Epstein, S. E., Morrow, A. G., 1978, Long term clinical course and symptomatic status of patients after operative treatment for hypertrophic subaortic stenosis, Circulation, 57:1205.
Maron, B. J., Lipson, L. C., Roberts, W. C., Savage, D. D., Epstein, S. E., 1978a, ‘Malignant’ hypertrophic cardiomyopathy, Amer. J. Cardiol., 41:1133–1140.
Maron, B. J., Epstein, S. E., Roberts, W. C., 1979, Hypertrophic cardiomyopathy and transmural myocardial infarction without significant atherosclerosis of the extramural coronary artery, Amer. J. Cardiol., 43:1086–1102.
Mason, J. W., Billingham, M. E., Ricci, D. R., 1980, Treatment of acute inflammatory myocarditis assisted by endomyocardial biopsy, Amer. J. Cardiol., 45:1037.
Murgo, J. P., et al., 1980, Dynamics of left ventricular ejection in obstructive and non-obstructive hypertrophic cardiomyopathy, Amer. J. Cardiol., 45:6.
Reitz, B. A., Epstein, S. E., Henry, W. L., Conkle, D. M., Iskoitz, S. B., Redwood, B. R., Morrow, A. G., 1975, Operative treatment in hypertrophic subaortic stenosis. Techniques and the results of pre and post operative assessment in 83 patients, Circulation, 52:88.
Report of the WHO/ISFC Task Force on the Definition and Classif ication of cardiomyopathies, Brit. Heart J., 1972, 34:545.
Rosing, D. R., Kent, K. M., Borer, J. S., Seides, S. F., Maron, B. J., Epstein, S. E., 1979 a, Verapamil therapy: A new approach to the pharmacological treatment of hypertrophic cardiomyopathy; I, hemodynamic effects, Circulation, 60:1201.
Rosing, D. R., Kent, K. M., Maron, B. J., Epstein, S. E., 1979b, Verapamil therapy: A new approach to the pharmacological treatment of hypertrophic cardiomyopathy; II, effects on exercise capacity and symptomatic status, Circulation, 60:1208–1213.
Rosing, D. R. et al., 1981, Verapamil therapy: a new approach to the pharmacological treatment of hypertrophic cardiomyopathy; III, the effect of long term administration, Amer. J. Cardiol., 48:545.
Sanderson, J. E., Traill, T. A., Sutton, M. G. St.J., Brown, D. J., Gibson, D. G., Goodwin, J. F., 1978, Left ventricular relaxation and filling in hypertrophic cardiomyopathy. An echocardiographic study, Brit. Heart J., 40:596.
Sharma, B., Goodwin, J. F., 1978, Beneficial effects of Salbutamol on cardiac function in severe congestive cardiomyopathy. Effects on systolic and diastolic function of the left ventricle, Circulation, 58:449.
Sharpe, D. N. et al., 1980, Low dose Captopril in chronic heart failure: acute hemodynamic effect and long term treatment, Lancet, 2:1154.
Spry, C. J. F., Tai, P. C., 1976, Studies in blood eosinophils. II, patients with Löffler’s cardiomyopathy, Clin. Exper. Immunol., 24:423.
Swanton, R. H. et al., 1977, Haemodynamic studies of beta blockade in hypertrophic cardiomyopathy, Europ. J. Cardiol., 5:327.
Waa stein, F., Hjalmasson, A., Vonrausker, E., Wolenkin, I., 1975, Effect of clinical beta adrenergic blockade in congestive cardiomyopathy, Brit. Heart J., 37:1022.
Webb-Peploe, M. M., Croxson, R. S., Oakley, C. M., Goodwin, J. F., 1971, Cardioselective beta adrenergic blockade in hypertrophic obstructive cardiomyopathy, Postgrad. Med. J., (suppl.), 47:93–97.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1984 Springer Science+Business Media New York
About this chapter
Cite this chapter
Goodwin, J.F. (1984). Treatment of Cardiomyopathies. In: Chazov, E.I., Smirnov, V.N., Oganov, R.G. (eds) Cardiology. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-1824-9_8
Download citation
DOI: https://doi.org/10.1007/978-1-4757-1824-9_8
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-1826-3
Online ISBN: 978-1-4757-1824-9
eBook Packages: Springer Book Archive